King Charles Shows Resilience Amid Cancer Treatment, Continues Royal Duties

King Charles has demonstrated remarkable resilience by continuing with a demanding schedule of royal and state duties despite ongoing cancer treatment, as highlighted by James Chalmers, the Keeper of the Privy Purse, during the annual Sovereign Grant briefing. The financial report covering April 2024 to March 2025 reflects a return to normal business following the dual cancer diagnoses of the King and the Princess of Wales, a period described by the Prince of Wales as 'brutal' and possibly the hardest year of his life. Charles made a swift return to public engagements in April 2024, while the Princess of Wales resumed duties more gradually, later announcing she was cancer-free in early 2025. The Sovereign Grant remained stable at £86.3 million for the year, with a planned increase to £132 million next year, and the King is set to end the use of the royal train to modernize and reduce costs, opting instead for helicopter travel. The public has widely supported the royal couple's return to duties, underscoring the strong connection between the royal family and the public. These developments illustrate both the personal commitment of King Charles and the adaptability of the Royal Household amid challenging health circumstances.